Asia Stocks News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Asia Stocks Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Asia StocksNewsStocks to Buy: Nagaraj Shetti Recommends Aurobindo Pharma, NMDC Shares to Buy
Stocks to Buy: Nagaraj Shetti Recommends Aurobindo Pharma, NMDC Shares to Buy
Large Cap StocksAsia StocksStock Trading

Stocks to Buy: Nagaraj Shetti Recommends Aurobindo Pharma, NMDC Shares to Buy

•February 26, 2026
0
Mint (LiveMint) – Markets
Mint (LiveMint) – Markets•Feb 26, 2026

Companies Mentioned

NVIDIA

NVIDIA

NVDA

Why It Matters

The picks provide traders with actionable short‑term opportunities amid a volatile market driven by commodity spikes and geopolitical risk, underscoring the relevance of technical cues in Indian equity trading.

Key Takeaways

  • •Sensex fell after early gains, ending negative.
  • •Crude oil peak and US‑Iran tensions pressured markets.
  • •Aurobindo Pharma buy: ₹1,243 entry, ₹1,305 target.
  • •NMDC buy: ₹82.90 entry, ₹88 target.
  • •Technical chart shows resistance near 25,600 for Nifty.

Pulse Analysis

The Indian equity market opened on Thursday with a modest rally, driven by strong IT earnings and a brief uplift from Nvidia’s results. However, by early afternoon the Sensex slipped 0.34% to 81,994 and the Nifty 0.25% to 25,421 as profit‑taking intensified across FMCG, metals and real‑estate. A seven‑month high in crude‑oil prices, coupled with renewed US‑Iran nuclear tensions, added a risk‑off bias that echoed through Asian peers and U.S. futures. Institutional buying remained robust, yet it could not sustain the early momentum.

Nagaraj Shetti’s short‑term outlook zeroes in on two stocks that have cleared key technical thresholds. Aurobindo Pharma, trading near ₹1,260, is poised to break its consolidation ceiling, with expanding volume and a bullish RSI supporting a one‑week target of ₹1,305. The drugmaker benefits from stable demand for generic formulations and recent price‑adjustment cycles, which can amplify price moves in a thinly traded range. Shetti’s entry point at ₹1,243 offers a modest risk‑reward profile for traders seeking quick gains.

The second recommendation, NMDC Ltd, reflects a rebound in metal stocks after a mid‑February slump. Trading at ₹82.90, the miner has partially filled a bearish gap and shows bullish volume patterns, justifying a target of ₹88 within the same week. Rising iron‑ore imports and government infrastructure spending are expected to lift demand, while the broader commodities market remains sensitive to oil price volatility. For investors, the twin picks illustrate how technical signals combined with sector fundamentals can generate short‑term opportunities amid a choppy macro environment.

Stocks to buy: Nagaraj Shetti recommends Aurobindo Pharma, NMDC shares to buy

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...